Add to ORKGIntroduction: Little is known about virologic responses to early antiretroviral therapy (ART) in HIV-infected infants in resource-limited settings. We estimated the probability of achieving viral suppression within 2 years of ART initiation and investigated the factors associated with success. Methods: We analyzed all 190 infants from the Cameroon Pediacam who initiated ART by 12 months of age. The main outcome measure was viral suppression (<1000 copies/mL) on at least 1 occasion; the other outcome measures considered were viral suppression (<400 copies/mL) on at least 1 occasion and confirmed viral suppression (both thresholds) on 2 consecutive occasions. We used competing-risks regression for a time-to-event analysis to estimate the cumu...
BACKGROUND: There are few data about disease progression and response to antiretroviral therapy (ART...
BACKGROUND: There is little data on responses to combination antiretroviral therapy (cART) among HIV...
BACKGROUND:: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance....
Introduction: Little is known about virologic responses to early antiretroviral therapy (ART) in HIV...
International audienceIntroduction: Little is known about virologic responses to early antiretrovira...
International audienceAbstract Background In most studies, the virological response is assessed duri...
Early initiation of antiretroviral therapy and adherence to achieve viral load suppression (VLS) are...
Background: There are limited published data on the outcomes of infants starting antiretroviral th...
OBJECTIVES: Infants infected with HIV-1 perinatally despite single-dose nevirapine progress rapidly....
Background: Viral load is still the marker of choice for monitoring adherence to combined antiretrov...
Objective: In the absence of treatment, rapid progression to AIDS occurs in approximately 20% of HIV...
BACKGROUND There are limited published data on the outcomes of infants starting antiretroviral th...
Background: There is little data on responses to combination antiretroviral therapy (cART) among HIV...
Objective: To describe the degree of HIV disease progression in infants initiating antiretroviral th...
There is limited data on virologic outcome and its correlates among HIV-infected children in resourc...
BACKGROUND: There are few data about disease progression and response to antiretroviral therapy (ART...
BACKGROUND: There is little data on responses to combination antiretroviral therapy (cART) among HIV...
BACKGROUND:: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance....
Introduction: Little is known about virologic responses to early antiretroviral therapy (ART) in HIV...
International audienceIntroduction: Little is known about virologic responses to early antiretrovira...
International audienceAbstract Background In most studies, the virological response is assessed duri...
Early initiation of antiretroviral therapy and adherence to achieve viral load suppression (VLS) are...
Background: There are limited published data on the outcomes of infants starting antiretroviral th...
OBJECTIVES: Infants infected with HIV-1 perinatally despite single-dose nevirapine progress rapidly....
Background: Viral load is still the marker of choice for monitoring adherence to combined antiretrov...
Objective: In the absence of treatment, rapid progression to AIDS occurs in approximately 20% of HIV...
BACKGROUND There are limited published data on the outcomes of infants starting antiretroviral th...
Background: There is little data on responses to combination antiretroviral therapy (cART) among HIV...
Objective: To describe the degree of HIV disease progression in infants initiating antiretroviral th...
There is limited data on virologic outcome and its correlates among HIV-infected children in resourc...
BACKGROUND: There are few data about disease progression and response to antiretroviral therapy (ART...
BACKGROUND: There is little data on responses to combination antiretroviral therapy (cART) among HIV...
BACKGROUND:: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance....